Lee, H., Ravizzini, G., Wixom, J., Chauhan, A., Fayad, L., Nair, R., Westin, J., Henderson, J., Aboismail, E., Flowers, C., Wang, M., Castillo, L. M. (2025). Interim PET-adapted de-escalation chemotherapy regimen for advanced stage classical Hodgkin lymphoma using brentuximab vedotin, pembrolizumab, doxorubicin, and dacarbazine: Phase 2 study. Blood. https://doi.org/10.1182/blood-2025-153